The compound is researched from the patent literature for its anxiolytic Homes and diminished sedative, hypnotic, and ataxic aspect-effects, but it does not seem like licensed for medical use. Łukasik-Głebocka et al One pharmacokinetics review confirmed that a dose of 0.five mg flubromazolam induced sturdy sedative effects that lasted https://augustpziom.atualblog.com/42580062/not-known-facts-about-flubromazolam-half-life